MF · holdings as filed 2026-04-30

What's inside BIPIX?

BIOTECHNOLOGY ULTRASECTOR PROFUND
Holdings
147
positions in the fund
Top 10
39%
of fund assets
Expense ratio
1.52%
net, per year
Fund size
$183M
total net assets
Top 15 holdings
1
N/A
27.87%
2
AGPXXINVESCO GVT & AGNCY-INST
2.05%
3
APLSUSDAPELLIS PHARMACEUTICALS INC
1.35%
4
RVMDREVOLUTION MEDICINES INC
1.19%
5
TVTXTRAVERE THERAPEUTICS INC
1.17%
6
ARWRARROWHEAD PHARMACEUTICALS IN
1.04%
7
TWSTTWIST BIOSCIENCE CORP
1.03%
8
SMMTSUMMIT THERAPEUTICS INC
1.01%
9
ALKSALKERMES PLC
1.00%
10
TGTXTG THERAPEUTICS INC
0.99%
11
MDGLMADRIGAL PHARMACEUTICALS INC
0.99%
12
BEAMBEAM THERAPEUTICS INC
0.96%
13
APGEAPOGEE THERAPEUTICS INC
0.91%
14
SRRKSCHOLAR ROCK HOLDING CORP
0.89%
15
PRAXPRAXIS PRECISION MEDICINES I
0.88%
Sectors
1Health Care
69%
2Unclassified
32%
3Industrials
1%
4Financials
0%
Geography
1United States
68%
2Unclassified
30%
3Ireland
1%
4Switzerland
1%
5Bermuda
1%
6Virgin Islands, British
0%
7Netherlands
0%
8Germany
0%
Hold BIPIX alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings (as of 2026-04-30); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.